Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Li, Jing Wei ^a   Xu, Cui ^b   Fan, Ye ^a   Wang, Yong ^a   Xiao, Ying Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The 305 Hospital of Chinese PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; PHOSPHATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; PHOSPHATE BLOOD LEVEL; PREDICTION; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; FEMALE; KIDNEY; MALE; META ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; RISK FACTOR;

ALKALINE PHOSPHATASE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY; MALE; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC; RISK; RISK FACTORS;

EID: 84904501755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102276     Document Type: Article

References (60)

1. Tanhauserova V, Kuricova K, Pacal L, Bartakova V, Rehorova J, et al. (2014) Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality. Clinical Chemistry and Laboratory Medicine 52: 77-83.
2. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, et al. (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19: 2193-2203.
3. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, et al. (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 1119-1127.
4. Natoli JL, Boer R, Nathanson BH, Miller RM, Chiroli S, et al. (2013) Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrol 14: 88.
5. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
6. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC (2006) Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 163: 1042-1052. (Pubitemid 43987597)
7. Wells G, Shea B, O'connell D, Peterson J, Welch V, et al. (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
8. Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata Journal 6: 40.
9. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB (2013) Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. Circulation.
10. Duval S, Tweedie R (2000) A nonparametric "trim and fill" method of accounting for publication bias in meta-analysis. Journal of the American Statistical Association 95: 89-98.
11. Figueiredo CP, Rajamannan NM, Lopes JB, Caparbo VF, Takayama L, et al. (2013) Serum phosphate and hip bone mineral density as additional factors for high vascular calcification scores in a community-dwelling: the Sao Paulo Ageing & Health Study (SPAH). Bone 52: 354-359.
12. Cancela AL, Santos RD, Titan SM, Goldenstein PT, Rochitte CE, et al. (2012) Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS One 7: e36883.
13. Kim J, Song TJ, Song D, Lee HS, Nam CM, et al. (2013) Serum Alkaline Phosphatase and Phosphate in Cerebral Atherosclerosis and Functional Outcomes After Cerebral Infarction. Stroke.
14. Linefsky JP, O'Brien KD, Katz R, de Boer IH, Barasch E, et al. (2011) Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol 58: 291-297.
15. Vyssoulis G, Karpanou E, Tzamou V, Kyvelou SM, Michaelidis A, et al. (2010) Serum phosphate in white-coat hypertensive patients: focus on dipping status and metabolic syndrome. Hypertens Res 33: 825-830.
16. Cheung BM, Ong KL, Wong LY (2009) Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004. Int J Cardiol 135: 156-161.
17. Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, et al. (2010) Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol 5: 1064-1071.
18. Chonchol M, Dale R, Schrier RW, Estacio R (2009) Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes. American Journal of Medicine 122: 380-386.
19. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, et al. (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of Internal Medicine 167: 879-885. (Pubitemid 46762749)
20. Dominguez JR, Kestenbaum B, Chonchol M, Block G, Laughlin GA, et al. (2013) Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: The osteoporotic fractures in men (MrOS) study. American Journal of Kidney Diseases 61: 555-563.
21. Ess M, Heitmair-Wietzorrek K, Frick M, Umlauf N, Ulmer H, et al. (2013) Serum phosphate and long-term outcome among patients with stable heart failure. J Card Fail 19: 25-30.
22. Fleming KM, West J, Aithal GP, Fletcher AE (2011) Abnormal liver tests in people aged 75 and above: prevalence and association with mortality. Aliment Pharmacol Ther 34: 324-334.
23. Foley RN, Collins AJ, Ishani A, Kalra PA (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156: 556-563.
24. Grandi NC, Brenner H, Hahmann H, Wusten B, Marz W, et al. (2012) Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart 98: 926-933.
25. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528. (Pubitemid 41725150)
26. Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, et al. (2013) Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int.
27. Larsson TE, Olauson H, Hagstrom E, Ingelsson E, Arnlov J, et al. (2010) Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 333-339.
28. McGovern AP, de Lusignan S, van Vlymen J, Liyanage H, Tomson CR, et al. (2013) Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study. PLoS One 8: e74996.
29. Park JB, Kang DY, Yang HM, Cho HJ, Park KW, et al. (2013) Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. Eur Heart J 34: 920-931.
30. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW (2010) Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 75: 1995-2002.
31. Slinin Y, Blackwell T, Ishani A, Cummings SR, Ensrud KE (2011) Serum calcium, phosphorus and cardiovascular events in post-menopausal women. International Journal of Cardiology 149: 335-340.
32. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, et al. (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784-1792.
33. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633. (Pubitemid 41532599)
34. van Kuijk JP, Flu WJ, Chonchol M, Valentijn TM, Verhagen HJM, et al. (2010) Elevated Preoperative Phosphorus Levels Are an Independent Risk Factor for Cardiovascular Mortality. American Journal of Nephrology 32: 163-168.
35. Wannamethee SG, Sattar N, Papcosta O, Lennon L, Whincup PH (2013) Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 33: 1070-1076.
36. Webber M, Krishnan A, Thomas NG, Cheung BM (2010) Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005-2006. Clin Chem Lab Med 48: 167-173.
37. Westerberg PA, Tivesten A, Karlsson MK, Mellstrom D, Orwoll E, et al. (2013) Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs). BMC Nephrology 14.
38. Bates CJ, Hamer M, Mishra GD (2012) A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteoporos Int 23: 457-466.
39. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC (2011) Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161: 956-962.
40. Cheung BM, Ong KL, Cheung RV, Wong LY, Wat NM, et al. (2008) Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clin Chem Lab Med 46: 523-527. (Pubitemid 351820368)
41. Yousaf F, Charytan C (2014) Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism. Renal Failure 36: 131-138.
42. Onufrak SJ, Bellasi A, Cardarelli F, Vaccarino V, Muntner P, et al. (2009) Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. American Journal of Epidemiology 169: 67-77.
43. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, et al. (2011) Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med 124: 566 e561-567.
44. Celik E, Guzel S, Abali R, Guzelant AY, Celik Guzel E, et al. (2013) The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women. Minerva Med 104: 497-504.
45. Liu X, Guo Q, Feng X, Wang J, Wu J, et al. (2014) Alkaline Phosphatase and Mortality in Patients on Peritoneal Dialysis. Clin J Am Soc Nephrol.
46. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, et al. (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176.
47. Onufrak SJ, Bellasi A, Shaw LJ, Herzog CA, Cardarelli F, et al. (2008) Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 199: 424-431.
48. Aronson D, Kapeliovich M, Hammerman H, Dragu R (2013) The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction. PLoS ONE 8.
49. Lippi G, Montagnana M, Salvagno GL, Targher G, Guidi GC (2009) Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients. Diabetes Res Clin Pract 84: e3-5.
50. Shin S, Kim KJ, Chang HJ, Cho I, Kim YJ, et al. (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 33: 2873-2881.
51. Lau WL, Pai A, Moe SM, Giachelli CM (2011) Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis 18: 105-112.
52. Chue CD, Townend JN, Steeds RP, Ferro CJ (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96: 817-823.
53. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, et al. (2008) The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19: 1092-1105.
54. Rajamannan NM (2011) Serum phosphate concentrations: a novel pre-clinical biomarker for cardiovascular calcification. J Am Coll Cardiol 58: 298-299.
55. Ellam TJ, Chico TJ (2012) Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220: 310-318.
56. Eastman JR, Bixler D (1977) Serum alkaline phosphatase: normal values by sex and age. Clin Chem 23: 1769-1770. (Pubitemid 8177413)
57. Maxwell DB, Fisher EA, Ross-Clunis HA 3rd, Estep HL (1986) Serum alkaline phosphatase in diabetes mellitus. J Am Coll Nutr 5: 55-59. (Pubitemid 16112982)
58. Iqbal MP, Mehboobali N, Azam I, Tareen AK (2013) Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D. Clin Chim Acta 425: 192-195.
59. Cupisti A, Gallieni M, Rizzo MA, Caria S, Meola M, et al. (2013) Phosphate control in dialysis. Int J Nephrol Renovasc Dis 6: 193-205.
60. Sterne JA, Egger M, Smith GD (2001) Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ: British Medical Journal 323: 101.